Findings show method to better prepare human lung tissue for study; it represents the latest mass spectrometry-based omics advances.

To thwart pathogens, researchers in the epidemiology field of infectious disease (ID) prediction are continuously trying to forecast when, where, and how an ID event will occur.

Silicone wristbands could be more convenient option for collecting exposure data.

PNNL computational neuroscientist Rogene Eichler West honored with the International Society for Neuroregulation & Research Joseph and Ann Marie Horvat Distinguished Service Award.

Kate Doty was invited to lend her expertise as guest editor for the International Journal of Nuclear Security on a special issue on women in nuclear security.

Scientists can detect the virus that causes COVID-19 by using a bubble that spills its contents like a piñata when encountering the virus.

Nonproliferation Policy and Law Analyst, Chanel Chauvet, served as the legal expert in the International Atomic Energy Agency's effort to update Uzbekistan's Integrated Nuclear Security Support Plan.

Interns dive into important research that addresses national needs.

John VerWey, East Asia national security advisor, delivered remarks on competition in global supply chains at a U.S.-China Economic Security Review Commission hearing in June 2022.

TransMED analyzes patient data from similar diseases across multiple sources to understand COVID-19 patient outcome risk factors.

The Washington State Academy of Sciences added six people from PNNL to its 2022 class of inductees.

The virus that causes COVID-19 takes over the body’s fat-processing system and boosts cellular triglycerides as it causes disease.

A new, state-of-the-art training facility in Larnaca, Cyprus provides unique training opportunities for border security officials from partner nations.

PNNL Hydrogen Safety Panel supports a fundamental hydrogen safety credential deployed through the Center for Hydrogen Safety.

The Department of Homeland Security Science and Technology Virtual First Responder Capitol Hill Showcase highlighted PNNL work in fentanyl detection standards and database libraries.

PNNL scientists have developed a new mass spectrometry method for in-depth analysis of proteins in individual cells.

The paper was recognized by the Society of Toxicology’s Medical Device and Combination Product Specialty Section.

Proteomics revealed molecular mechanisms by which the drug Verapamil could prolong beta cell function in early-onset type 1 diabetes patients.

Sarah Frazar, a group manager in the National Security Directorate at PNNL, was recently elected Vice Chair of the Board of Trustees for the World Affairs Council of Seattle.

Study highlights microbiome’s role in regulating xenobiotic metabolism.